Document is current
Any future updates will be listed below
-
Authors
Murphy, Sara A
Li, Jiaqi
Sahu, Upasana
Swanner, Jessica
Lewis, Cole T
Anchang, Benedict
Cui, Yan
Chiocca, E. Antonio
Kaur, Balveen https://orcid.org/0000-0001-7738-0804
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03152318 at ClinicalTrials.govnct03801902 at ClinicalTrials.govDocuments that mention this clinical trial
Longitudinal stereotactic injections of oncolytic immunoactivating rQNestin34.5v.2 (CAN-3110) with concomitant biopsies for “-omic” analyses in recurrent glioblastoma (GBM).
https://doi.org/10.1200/jco.2024.42.16_suppl.tps2097
896 Oncolytic herpes simplex virus immuno-virotherapy in combination with tigit immune checkpoint blockade to treat glioblastoma
https://doi.org/10.1136/jitc-2022-sitc2022.0896
CD73 blockade enhances antitumor efficacy of oHSV in solid tumors by increasing macrophage-mediated antigen presentation
https://doi.org/10.1136/jitc-2025-013640
nct05431270 at ClinicalTrials.govDocuments that mention this clinical trial
CD73 blockade enhances antitumor efficacy of oHSV in solid tumors by increasing macrophage-mediated antigen presentation
https://doi.org/10.1136/jitc-2025-013640
nct05174585 at ClinicalTrials.govDocuments that mention this clinical trial
CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models
https://doi.org/10.1136/jitc-2023-006842
CD73 blockade enhances antitumor efficacy of oHSV in solid tumors by increasing macrophage-mediated antigen presentation
https://doi.org/10.1136/jitc-2025-013640
nct05143970 at ClinicalTrials.govDocuments that mention this clinical trial
CD73 blockade enhances antitumor efficacy of oHSV in solid tumors by increasing macrophage-mediated antigen presentation
https://doi.org/10.1136/jitc-2025-013640
Documents that mention this clinical trial
CD73 blockade enhances antitumor efficacy of oHSV in solid tumors by increasing macrophage-mediated antigen presentation
https://doi.org/10.1136/jitc-2025-013640
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS127473)
National Institute of Dental and Craniofacial Research (R01DE032178)
Cancer Prevention and Research Institute of Texas (CPRIT RP240610)
National Cancer Institute (P01CA163205)
Georgia Cancer Center Paceline Trainee Research Award (8469T)
- License Information
